期刊文献+

髓过氧化物酶-抗中性粒细胞胞浆抗体相关性血管炎活动期血清标志物的研究 被引量:9

Investigation on the serum marker of MPO-ANCA associated vasculitis in active phase
在线阅读 下载PDF
导出
摘要 目的:抗中性粒细胞胞浆抗体( antineutrophil cytoplasmic antibodies, ANCA)相关性血管炎( ANCA-associated vasculitis, AAV)是一组累及全身小血管的致死性疾病,髓过氧化物酶( myeloperoxidase, MPO)为ANCA识别的主要抗原之一。文中通过检测活动期MPO-AAV患者外周血中MPO、活化补体C5a片段及铜蓝蛋白(ceruloplasmin, Cp)水平的变化,进一步探索上述血清标志物的临床意义。方法选取活动期MPO-AAV患者132例为病例组,健康志愿者30例为对照组。通过间接免疫荧光法及ELISA法分别检测病例组的p-ANCA及MPO-ANCA;ELISA法检测并比较2组的MPO、C5a及Cp水平;根据伯明翰血管炎活动性评分(birmingham vasculitis activity score, BVAS)量表,记录患者的BVAS,分析病例组中MPO、C5a、Cp及MPO-ANCA间的相关性,并探讨上述各指标与BVAS的关系。结果外周血MPO、C5a、Cp水平在病例组中分别为400.7(333.5~506.1)IU/L、336.7(277.6~403.5)ng/mL、481.1(387.9~535.9)ng/mL,在对照组中分别为286.9(225.5~329.1)IU/L、236.8(204.2~304.1)ng/mL、326.9(177.1~405.5)ng/mL,病例组上述各指标均明显高于对照组,差异均具有统计学意义(P<0.05)。病例组MPO与Cp呈显著正相关( r=0.663,P<0.001);C5a与MPO、Cp的相关系数分别为0.792、0.637,均呈显著正相关( P<0.001);MPO-ANCA与总BVAS、肾BVAS及肺BVAS的相关系数分别为0.247、0.339、0.191,均呈显著正相关( P<0.05);p-ANCA与肾BVAS呈正相关( r=0.208,P<0.05);C5a与肾BVAS呈负相关( r=-0.207,P<0.05)。结论活动期MPO-AAV患者周围血中MPO、Cp及C5a水平均明显升高,相互之间及与ANCA之间复杂的相互作用可能共同影响MPO-AVV的临床损害,其中,MPO-ANCA存在较明显影响,C5a对肾损害影响较明显。 Objective Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis(AAV)is a systemic necrotizing small-vessel vasculitis, and myeloperoxidase(MPO) is one of the main antigens that ANCA can recognize.This study was to investigate the clinical significance of MPO, activated complement C5a fragment and ceruloplasmin ( Cp) in the peripheral blood of patients with MPO-ANCA associated vasculitis ( MPO-AAV) in active phase by observing their changes. Methods 132 MPO-AAV patients at active stage were selected as the patient group, while the control group was made up of 30 healthy controls.Peri-nuclear ANCA (p-ANCA) and MPO-ANCA in the patient group were detected by IIF and ELISA, respectively.The levels of MPO, Cp and C5a in both groups were tested by ELISA.The Birmingham vasculitis activity score (BVAS) of every patient was calculated.In the patient group, the relationship among MPO, Cp, C5a and MPO-ANCA were analysed, and the association between BVAS and each of them was also explored. Results The levels of MPO, CP, C5a in the patient group were significantly higher than those in the health control group [MPO:400.7(333.5---506.1) vs 286.9(225.5--329.1)IU/L, P30.001;C5a:336.7 (277.6--403.5) vs 236.8 (204.2--304.1) ng/mL, P30.001;Cp:481.1 (387.9--535.9) vs 326.9 (177.10---405.5) ng/mL,P30.001].The associations between MPO and Cp, C5a and MPO, C5a and Cp in the patient group were statistically significant ( r=0.663, P30.001;r=0.792, P30.001;r=0.637, P30.001, respectively).No significant correlation was found in MPO-ANCA and any of these indexes.MPO-ANCA had a positive association with the total BVAS, the kidney BVAS, and the lung BVAS ( r=0.247, P=0.004;r=0.339,P30.001 and r=0.191, P=0.028, respec-tively) .p-ANCA had a positive correlation with the kidney BVAS ( r=0.208, P=0.017) while C5a had a negative correlation with the kidney BVAS ( r=-0.207, P=0.018) . Conclusion The levels of MPO, Cp and C5a increased significantly in the peripheral blood of MPO-AAV patients in active phase.The complex interactions among MPO, Cp, C5a and ANCA might influence the clinical damage in MPO-AAV.Notablely, the influence from MPO-ANCA might be most obvious while C5a might affect renal damage more markedly.
出处 《医学研究生学报》 CAS 北大核心 2015年第4期406-410,共5页 Journal of Medical Postgraduates
基金 中华医学会临床医学科研专项资金(08010290107)
关键词 抗中性粒细胞胞质抗体 髓过氧化物酶 铜蓝蛋白 相关性血管炎 C5a Antineutrophil cytoplasmic antibodies Myeloperoxidase C5a Ceruloplasmin ANCA associated vasculitis
作者简介 通讯作者:帅宗文,E-mail:shuaizongwen@medmail.com.cn
  • 相关文献

参考文献36

  • 1Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum, 2013, 65(1): 1-11.
  • 2Xu PC, Chen M, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients[J].Clin Exp Nephrol, 2013, 17(5): 705-707.
  • 3Chen M, Yu F, Zhang Y, et al. Characteristics of Chinese patients with Wegener′s granulomatosis with anti-myeloperoxidase autoantibodies[J].Kidney Int, 2005, 68(5): 2225-2229.
  • 4Chen M, Yu F, Zhang Y, et al. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre [J].Postgrad Med J, 2005, 81(961): 723-727.
  • 5吕远帆,帅宗文,张铭明,胡子盈.髓过氧化物酶-抗中性粒细胞胞质抗体相关性血管炎132例临床分析[J].中华风湿病学杂志,2014,18(5):308-312. 被引量:25
  • 6Little MA, Smyth L, Salama AD, et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis[J].Am J Pathol, 2009, 174(4): 1212-1220.
  • 7Xiao H, Heeringa P, Hu PQ, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice[J].J Clin Invest, 2002, 110(7): 955-963.
  • 8Schlieben DJ, Korbet SM, Kimura RE, et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs[J].Am J Kidney Dis, 2005, 45(4): 758-761.
  • 9Kallenberg CG, Heeringa P. Complement is crucial in the pathogenesis of ANCA-associated vasculitis[J].Kidney Int, 2013, 83(1): 16-18.
  • 10Hao J, Chen M, Zhao MH. Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation[J].Mol Immunol, 2013, 54(1): 68-73.

二级参考文献20

  • 1Jennette JC,Falk RJ,Bacon PA,et al.2012 revised international Chapel Hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65:1-11.
  • 2Reinhold-Keller E,Herlyn K,Wagner-Bastmeyer R,et al.Stable incidence of primary systemic vasculitides over five years:results from the German vasculitis register[J].Arthritis Rheum,2005,53:93-99.
  • 3Fujimoto S,Watts RA,Kobayashi S,et al.Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K[J].Rheumatology (Oxford),2011,50:1916-1920.
  • 4Chen M,Yu F,Zhang Y,et al.Clinical[corrected]and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides:a study of 426 patients from a single centre[J].Postgrad Med J,2005,81:723-7.
  • 5Oh JS,Lee CK,Kim YG,et al.Clinical features and outcomes of microscopic polyangiitis in Korea[J].J Korean Med Sci,2009,24:269-274.
  • 6Ahn JK,Hwang JW,Lee J,et al.Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea[J].Rheumatol Int,2012,32:2979-2986.
  • 7Roth A J,Ooi JD,Hess J J,et al.Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis[J].J Clin Invest,2013,123:1773-1783.
  • 8Xiao H,Heeringa P,Hu P,et al.Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomeru lonephritis and vasculitis in mice[J].J Clin Invest,2002,110:955-963.
  • 9Little MA,Smyth CL,Yadav R,et al.Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte microvascular interactions in vivo[J].Blood,2005,106:2050-2058.
  • 10Leavitt RY,Fauci AS,Bloch DA,et al.The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis[J].Arthritis Rheum,1990,33:1101-1107.

共引文献24

同被引文献79

  • 1杨志寅.现代医学科学发展中的缺憾与思考[J].中华诊断学电子杂志,2013,1(1). 被引量:100
  • 2陈柏荣,危小良,彭湖,罗礼云,林岫芳.髓过氧化物酶与冠状动脉慢血流的相关性[J].中国动脉硬化杂志,2015,23(2):185-187. 被引量:10
  • 3韦格纳肉芽肿病诊治指南(草案)[J].中华风湿病学杂志,2004,8(9):562-564. 被引量:44
  • 4Korkmaz BfJenne DE,Gauthier F. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases [J]. Int Immunopharmacol,2013,17(4);1198-1205.
  • 5Dobric S5Popovic D, Nikolic M, et al. Anti-neutrophil cytoplasmic anti-bodies (ANCA)specific for one or several antigens;useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis [J]. Clin Chem Lab Med,2012,50(3):503-509.
  • 6Qiu JY,Liu GJ,Yang XJ. The effect of serum test of patients with ulcerative colitis on diagnosis and prognosis [J]. Exp Lab Med,2010,28(2):153-154.
  • 7Tervaert JWC,Damoiseaux J. Fifty years of antineutrophil cytoplasmic antibodies(ANCA)testing:do we need to revise the international consensus statement on testing and reporting on ANCA [J], APMIS Suppl,2013,6(127):55-59.
  • 8Stinton LM, Bentow C,Mahler M,et al. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)LJ]. PLoS One,2014,9(ll):e112877.
  • 9Deniziaut G,Ballot E. Antineutrophil cytoplasmic autoantibodies (ANCA)in autoimmune hepatitis and primary sclerosing cholangitis [J]. Clin Res Hepatol Gastroenterol,2013,37(1):105-107.
  • 10Liu KY,Comstock SS,Shunk JM. Natural killer cell populations and cytotoxic activity in pigs fed mother's milk, formula,orformula supplemented with bovine lactoferrin [J]. Pediatr Res,2013,74(4):402-407.

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部